Litigation Watch: ARTHRITIS DRUGS is a monthly newsletter for attorneys, focusing on drugs used to treat osteo and rheumatoid arthritis: Arava, Enbrel, Remicade, Humira, Vioxx, Celebrex and more. These drugs are already the subject of litigation following claims that they cause everything from liver damage to cancer, heart failure and strokes. Each issue features case news, interviews, legislative and FDA updates, and reviews from current medical literature.
Arthritis Drugs - Issue: 32
Federal Judge Reinstates Vioxx Lawsuit Despite Plaintiff Counsel's Neglect
Texas Judge Reduces Punitive Damage Award in Widow's Vioxx Suit
FDA Proposes Stronger Labeling Regulations for Common Painkillers
FDA Approves Celebrex for Treatment of Juvenile Rheumatoid Arthritis
Merck Moves to Dismiss Philadelphia Vioxx Action for Forum Issues
Ala. Jury Finds Merck Adequately Warned about Vioxx Risks
Plaintiff Says Arava Manufacturer Breached Duty to Warn of Risks
Texas Jury Awards $19.4 Million to Plaintiffs in Remicade Injury Suit
